TelsaMed products are the result of extensive market research globally into laboratory studies for combating the COVID-19 pandemic and the SARS-CoV-2 and MERS-CoV viruses, and into a series of academic studies and clinical trial
TelsaMed is a subdivision of Telsa.
Telsa offers high quality services since 1993. The company manufactures technological systems for all technical needs using innovative techniques and dealing with problems that are difficult to be solved by most experts.